1 December 2020 - Late treatment study
CPAP Treatment In COVID-19 Patients: A Retrospective Observational Study In The Emergency Department
et al., Research Square, doi:10.21203/rs.3.rs-113418/v1 (Preprint)
Small 52 patient retrospective study of patients with acute respiratory failure showing lower rates of intubation with HCQ.
|
risk of mechanical ventilation, 40.0% lower, RR 0.60, p = 0.30, treatment 12 of 40 (30.0%), control 6 of 12 (50.0%), NNT 5.0.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Capsoni et al., 12/1/2020, retrospective, Italy, Europe, preprint, 13 authors, average treatment delay 7.0 days.
Please send us
corrections, updates, or comments. Vaccines and treatments are both
valuable and complementary. All practical, effective, and safe means
should be used. Elimination of COVID-19 is a race against viral evolution. No
treatment, vaccine, or intervention is 100% available and effective for all
current and future variants. Denying the efficacy of any method increases
mortality, morbidity, collateral damage, and the risk of endemic status. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. WCH
and FLCCC provide
treatment protocols.